Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Zubotamig is a bispecific T-cell engager (BiTE) antibody targeting B7-H4 (VTCN1) and CD3e to redirect T cells to tumors expressing B7-H4. It is in preclinical stages for solid tumor therapies.
仅用于科研。不用于诊断过程。未经明确授权不得转售。